USFDA classifies Sun Pharma#39;s Halol manufacturing site for official action, may put all new approvals on hold
The OAI status implies that the USFDA may put all new approvals from the Halol facility on hold till the outstanding corrective actions are completed.from Moneycontrol Business News https://ift.tt/3artekw
Comments
Post a Comment